(Q39309529)

10 September 2017

1 reference

title

Antiviral therapy with small particle aerosols (English)

1 reference

10 September 2017

1 reference

V Knight

1

1 reference

10 September 2017

B Gilbert

series ordinal

2

1 reference

10 September 2017

language of work or name

1 reference

1 December 1988

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

10 September 2017

published in

1 reference

10 September 2017

volume

7

1 reference

10 September 2017

issue

6

1 reference

10 September 2017

page(s)

721-731

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01975037

10 September 2017

exact match

0 references

cites work

Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84.

1 reference

https://api.crossref.org/works/10.1007%2FBF01975037

Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975037

Estimating the Dosage of Ribavirin Aerosol According to Age and Other Variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975037

Pharmacokinetics of ribavirin aerosol in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975037

Metabolism of ribavirin in respiratory syncytial virus-infected and uninfected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975037

Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975037

Treatment of influenza A (H1N1) virus infection with ribavirin aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975037

Inhibition of Rhinovirus Replication in Organ Culture by a Potential Antiviral Drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975037

Topical enviroxime against rhinovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975037

Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975037

Therapeutic activity of enviroxime against rhinovirus infection in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975037

Controlled trial of enviroxime against natural rhinovirus infections in a community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975037

Small particle aerosols of enviroxime-containing liposomes

21 January 2018

1 reference

12 December 2020

Amantadine Small-Particle Aerosol: Generation and Delivery to Man

1 reference

12 December 2020

Favorable outcome after treatment with amantadine and ribavirin in a pregnancy complicated by influenza pneumonia. A case report

1 reference

12 December 2020

Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic

1 reference

12 December 2020

Ribavirin small-particle aerosol treatment of influenza

1 reference

12 December 2020

Ribavirin aerosol for acute bronchiolitis

1 reference

12 December 2020

Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants

1 reference

12 December 2020

Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease.

1 reference

12 December 2020

Ribavirin treatment of viral pneumonitis in severe combined immunodeficiency disease

1 reference

12 December 2020

Treatment of Respiratory Viral Infection in an Immunodeficient Infant With Ribavirin Aerosol

1 reference

12 December 2020

Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

1 reference

12 December 2020

Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease

1 reference

12 December 2020

Metabolism of 5-amino-1-β-d-ribofuranosyl- imidazole-4-carboxamide and related five-membered heterocycles to 5′-triphosphates in human blood and L5178Y cells

1 reference

12 December 2020

The activity of enviroxime against rhinovirus infection in man

1 reference

12 December 2020

Mathematical model for the postnatal growth of the human lung.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01975037

1 reference

10 September 2017

1 reference